0001181431-13-026289.txt : 20130508 0001181431-13-026289.hdr.sgml : 20130508 20130508175344 ACCESSION NUMBER: 0001181431-13-026289 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130506 FILED AS OF DATE: 20130508 DATE AS OF CHANGE: 20130508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wotton Paul K CENTRAL INDEX KEY: 0001300997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 13825857 MAIL ADDRESS: STREET 1: C/O ANTARES PHARMA, INC. STREET 2: 707 EAGLEVIEW BOULEVARD, SUITE 414 CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1208 BUSINESS ADDRESS: STREET 1: 250 PHILLIPS BLVD STREET 2: SUITE 290 CITY: EWING STATE: NJ ZIP: 08618 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 250 PHILLIPS BLVD STREET 2: SUITE 290 CITY: EWING STATE: NJ ZIP: 08618 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 4 1 rrd378954.xml WOTTON MAY 6 X0306 4 2013-05-06 0 0001016169 ANTARES PHARMA, INC. ATRS 0001300997 Wotton Paul K C/O ANTARES PHARMA, INC. 100 PRINCETON SOUTH, SUITE 300 EWING NJ 08628 1 1 0 0 President and CEO COMMON STOCK 2013-05-06 4 M 0 10000 0.50 A 533547 D COMMON STOCK 2013-05-06 4 S 0 10000 4.0350 D 523547 D STOCK OPTION (RIGHT TO BUY) 0.50 2013-05-06 4 M 0 10000 0 D 2018-10-20 COMMON STOCK 10000 1605793 D The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The options vested in equal quarterly installments over three years following the grant date. Robert F. Apple as attorney-in-fact for Paul Wotton 2013-05-08